Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 2
2007 1
2009 1
2010 4
2011 2
2012 2
2013 2
2014 3
2016 7
2017 6
2018 8
2019 7
2020 7
2021 8
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, Yao X, Deshpande A, Zaidi S, Guglielmi A, Gnutti B, Nagarkatti N, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Jeong K, Zhao S, Buza N, Hui P, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Ardighieri L, Bilguvar K, Quick CM, Silasi DA, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Imielinski M, Schwartz PE, Alexandrov LB, Lifton RP, Schlessinger J, Santin AD. Choi J, et al. Among authors: zammataro l. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2025182118. doi: 10.1073/pnas.2025182118. Proc Natl Acad Sci U S A. 2021. PMID: 33876771 Free PMC article.
The chemokine system in cancer biology and therapy.
Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R. Mantovani A, et al. Among authors: zammataro l. Cytokine Growth Factor Rev. 2010 Feb;21(1):27-39. doi: 10.1016/j.cytogfr.2009.11.007. Epub 2009 Dec 8. Cytokine Growth Factor Rev. 2010. PMID: 20004131 Review.
Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer.
Perrone E, Lopez S, Zeybek B, Bellone S, Bonazzoli E, Pelligra S, Zammataro L, Manzano A, Manara P, Bianchi A, Buza N, Tymon-Rosario J, Altwerger G, Han C, Menderes G, Ratner E, Silasi DA, Azodi M, Hui P, Schwartz PE, Scambia G, Santin AD. Perrone E, et al. Among authors: zammataro l. Front Oncol. 2020 Feb 12;10:118. doi: 10.3389/fonc.2020.00118. eCollection 2020. Front Oncol. 2020. PMID: 32117765 Free PMC article.
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.
Matarazzo S, Melocchi L, Rezzola S, Grillo E, Maccarinelli F, Giacomini A, Turati M, Taranto S, Zammataro L, Cerasuolo M, Bugatti M, Vermi W, Presta M, Ronca R. Matarazzo S, et al. Among authors: zammataro l. Cancers (Basel). 2019 Aug 30;11(9):1277. doi: 10.3390/cancers11091277. Cancers (Basel). 2019. PMID: 31480336 Free PMC article.
AnnotateGenomicRegions: a web application.
Zammataro L, DeMolfetta R, Bucci G, Ceol A, Muller H. Zammataro L, et al. BMC Bioinformatics. 2014;15 Suppl 1(Suppl 1):S8. doi: 10.1186/1471-2105-15-S1-S8. Epub 2014 Jan 10. BMC Bioinformatics. 2014. PMID: 24564446 Free PMC article.
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin JA, Choi J, Santin AD. Bellone S, et al. Among authors: zammataro l. Cancer. 2022 Mar 15;128(6):1206-1218. doi: 10.1002/cncr.34025. Epub 2021 Dec 7. Cancer. 2022. PMID: 34875107 Free PMC article. Clinical Trial.
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.
Jalalirad M, Haddad TC, Salisbury JL, Radisky D, Zhang M, Schroeder M, Tuma A, Leof E, Carter JM, Degnim AC, Boughey JC, Sarkaria J, Yu J, Wang L, Liu MC, Zammataro L, Malatino L, Galanis E, Ingle JN, Goetz MP, D'Assoro AB. Jalalirad M, et al. Among authors: zammataro l. Oncogene. 2021 Apr;40(14):2509-2523. doi: 10.1038/s41388-021-01711-x. Epub 2021 Mar 5. Oncogene. 2021. PMID: 33674749 Free PMC article.
53 results